News
The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...
Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.
About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...
One of them is CRISPR Therapeutics ( CRSP -0.90%). It has an approved gene-editing therapy, but investors haven't been buying ...
14h
Pharmaceutical Technology on MSNStylus Medicine launches with $85m to advance in vivo gene editingStylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...
16h
Asian News International on MSNA new hope for patients suffering from potentially fatal rare heart disease: NUHCS is first in Asia to recruit patients for landmark gene editing clinical trialWhile receiving treatment for a car accident ten years ago, Mr Chua learnt that he had an abnormal build-up of protein in his ...
An appeals court has opened another chapter in the long-running CRISPR patent saga. | An appeals court has opened another ...
Synthego Corp., which makes gene-editing tools for drug developers and other researchers, filed for bankruptcy with plans to ...
Danforth Technology Company launched Spearhead Bio to make the process of gene editing faster and more efficient.
A new agtech company focused on enhancing gene editing for plants has launched in St. Louis, the Danforth Technology Company ...
In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results